Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Hwan-Jung Yun"'
Autor:
Myung-Won Lee, Jeong Suk Koh, Sora Kang, Hyewon Ryu, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Seon Young Kim, Seong Soo Kim, Deog-Yeon Jo
Publikováno v:
HemaSphere, Vol 7, p e8546104 (2023)
Externí odkaz:
https://doaj.org/article/bc925ca27dcc473bba07656700fb5c7a
Autor:
Sang Hoon Yeon M.D., Myung-Won Lee M.D., Pham Thi Thuy Duong M.D., Sora Kang M.D., Sungju Jee M.D., So-Young Ahn M.D., Hyewon Ryu M.D., Hyo-Jin Lee M.D., Jung Hye Kwon M.D., Hwan-Jung Yun M.D., Deog-Yeon Jo M.D., Ik-Chan Song M.D.
Publikováno v:
Integrative Cancer Therapies, Vol 21 (2022)
Purpose: To evaluate the role of the cardiopulmonary exercise test (CPET) with comorbidity index as a predictor of overall survival (OS) and non-relapse mortality (NRM) in patients with hematological malignancies who undergo allogeneic hematopoietic
Externí odkaz:
https://doaj.org/article/e8794ab5c4424a0fa029a11dc7358f55
Autor:
Yu Ri Kim, Soo-Jeong Kim, Yong Park, Sung Yong Oh, Hwan-Jung Yun, Yeung-Chul Mun, Jin Seok Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 5, Pp 1181-1189 (2021)
Background/Aims Febrile neutropenia (FN) interferes with the proper chemotherapy dose density or intensity in non-Hodgkin’s lymphoma (NHL) patients. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) ± rituximab ha
Externí odkaz:
https://doaj.org/article/03245739541c4ad5935bb6e9bece88de
Autor:
Ik-Chan Song, Sang Hoon Yeon, Myung-Won Lee, Hyewon Ryu, Hyo-Jin Lee, Hwan-Jung Yun, Seon Young Kim, Deog-Yeon Jo
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 5, Pp 1190-1203 (2021)
Background/Aims Recent changes in the diagnostic criteria for myeloproliferative neoplasms (MPNs) and increasing patient numbers necessitate updating of the data on vascular events in patients with such disorders. Methods In this single-center study,
Externí odkaz:
https://doaj.org/article/1171ae3cdf6c42e4a204252610a84058
Autor:
Kyung-Hee Lee, Tae Won Kim, Jung-Hun Kang, Jin-Soo Kim, Jin-Seok Ahn, Sun-Young Kim, Hwan-Jung Yun, Young-Jun Eum, Sung Ae Koh, Min Kyoung Kim, Yong Sang Hong, Jeong Eun Kim, Gyeong-Won Lee
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-9 (2017)
Abstract Background Controlled-release oxycodone/naloxone (OXN-CR) maintains the effect of opioid-induced analgesia through oxycodone while reducing the occurrence rate of opioid-induced constipation through naloxone. The present study was designed t
Externí odkaz:
https://doaj.org/article/872be79163264738b6f318f7b9f1cd0a
Publikováno v:
대한영상의학회지, Vol 75, Iss 2, Pp 151-156 (2016)
Air-leakage syndrome associated with graft-versus-host disease (GVHD) is a rare complication, but it is also reported as an independent predictor of a worse survival rate after stem cell transplantation. We report two cases of air-leakage syndrome as
Externí odkaz:
https://doaj.org/article/d2c7103b1d8f44de801e871bfdace9e5
Publikováno v:
Blood Research. 58:42-50
Autor:
Seong Hyun, Jeong, Seok Jin, Kim, Dok Hyun, Yoon, Yong, Park, Hye Jin, Kang, Youngil, Koh, Gyeong-Won, Lee, Won-Sik, Lee, Deok-Hwan, Yang, Young Rok, Do, Min Kyoung, Kim, Kwai Han, Yoo, Yoon Seok, Choi, Hwan Jung, Yun, Jun Ho, Yi, Jae-Cheol, Jo, Hyeon-Seok, Eom, Jae-Yong, Kwak, Ho-Jin, Shin, Byeong Bae, Park, Shin Young, Hyun, Seong Yoon, Yi, Ji-Hyun, Kwon, Sung Yong, Oh, Hyo Jung, Kim, Byeong Seok, Sohn, Jong Ho, Won, Se-Hyung, Kim, Ho-Sup, Lee, Cheolwon, Suh, Won Seog, Kim
Publikováno v:
Cancer Research and Treatment. 54:1268-1277
PurposeFebrile neutropenia (FN) can cause suboptimal treatment and treatment-related mortality (TRM) in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). Mate
Autor:
Sora Kang, Myung-Won Lee, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Deog-Yeon Jo, Jung Sun Kim, Jung Hye Kwon, Ji-Yeon Kim, Kyung-Ha Lee, Hyewon Ryu
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Autor:
Byoung Chul Cho, Soonmyung Paik, Joo Hang Kim, Hye Ryun Kim, Tae-Min Kim, Ji Hyun Lee, Min Goo Lee, Hwan Jung Yun, Nak-Jung Kwon, Bomi Kim, Jin Hee Sohn, Dong Hoe Koo, Eun Chang Choi, Se Hun Kim, Yoon Woo Koh, Se-Hoon Lee, Keon Uk Park, Dok-Hyun Yoon, Sung Bae Kim, Jong-Mu Sun, Byung Woog Kang, Myung-Ju Ahn, Mi Ran Yun, Inkyung Jung, Hyeong Ju Kwon, Han Sang Kim
Purpose: The goals of this study were to investigate the clinical activity, safety, and biomarkers of dacomitinib, an irreversible tyrosine kinase inhibitor of EGFR, HER2, and HER4, in recurrent and/or metastatic squamous cell carcinoma of the head a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438d127278f3d2e08e6c54ff715ede38
https://doi.org/10.1158/1078-0432.c.6523097.v1
https://doi.org/10.1158/1078-0432.c.6523097.v1